Oral cancer risk and molecular markers;Riesgo de cáncer oral y marcadores moleculares

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 9, Issue 5, 2004, Pages 377-384

  Chimenos Küstner, Eduardo ^a,b   Font Costa, Imma ^a   López López, José ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE   (Spain)

Author keywords

Epithelial dysplasia; Molecular markers; Oral leukoplakia; Oral squamous carcinoma; Tissue markers

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; BAG 1 PROTEIN; CELL SURFACE MARKER; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FAS ANTIGEN; FAS LIGAND; FIBROBLAST GROWTH FACTOR; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; MATRIX METALLOPROTEINASE; MOLECULAR MARKER; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P120; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; TELOMERASE; TUMOR MARKER; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER RISK; CLINICAL FEATURE; DENDRITIC CELL; DYSPLASIA; HUMAN; METASTASIS; MOUTH CANCER; PRECANCER; PROTEIN EXPRESSION; TUMOR GROWTH; BIOSYNTHESIS; METABOLISM; MOUTH TUMOR; REVIEW; RISK FACTOR;

HUMANS; MOUTH NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 17144374861     PISSN: 16984447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kim J, Shin DM, El-Naggar A, Lee JS, Corrales C, Lippman SM et al. Chromosome porysomy and histological characteristics in oral premalignant lesions. Cancer Epidemiol Biomarkers Prev 2001;10:319-25.
2. Joseph BK. Oral cancer prevention and detection. Med Princ Pract 2002;111:32-5.
3. Sudbo J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oraldysplasia. J Pathol 2001;194:303-13.
4. Werkmeister R, Brandt B, Joos V. Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol 2000;36:100-5.
5. De Vicente JC, Esteban I, Germanà A, Vega JA. Expresión de las proteínas de los proto-oncogenes ErbB-3 y ErbB-4 en el carcinoma oral de células escamosas: estudio piloto. Med Oral 2003;8:374-81.
6. Whyte DA, Broton CE, Shillitoe EJ. The unexplained survival of cells in oral cancer, what is the role of p53?. J Oral Pathol Med 2002;31:25-33.
7. Schliephake H. Prognostic relevance of molecular markers of oral cancer -A review. J Oral Maxillofac Surg 2003;32:233-45.
8. Mineta H, Miura K, Takebayashi S, Ueda Y, Misawa K, Haida H et al. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 2000;36:194-8.
9. 1 and cdk4 in human oral and pharyngeal squamous cell carcinomas. Oral Oncol 2000;36:334-9.
10. Tumuluri V, Thomas GA, Fraser IS. Analysis of the Ki-67 antigen at the invasive tumour iront of human oral squamous cell carcinoma. J Oral Pathol Med 2002;31:598-604.
11. Cano LC, Álvarez GJ, Valencia WA, Ramírez JA, Prada CA. Análisis del marcador tisular AgNOR en leucoplasia y carcinoma escamocelular oral. Medicina Oral 2002;7: 17-25.
12. Ries JC, Hassfurther E, Steininger H, Kloss FR, Wiltfang J, Girod SC, Neukam FW. Correlation of tclomerase activity, clinical prognosis and therapy in oral carcinogenesis. Anticancer Res 2001;21:1057-64.
13. Liao J, Mitsuyasu T, Yamane K, Ohishi M. Telomerase activity in oral and maxillofacial tumors. Oral Oncol 2000;36:347-52.
14. Lee B-K, Diebel E, Neukam FW, Wiltfarg J, Ries J. Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer. Int J Oncol 2001;19:1063-8.
15. Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin MI. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:45-50.
16. Yanamoto S, Kawasaki G, Yoshitomi Di, Mizuno A. P53, mdm2 and p21 expression in oral squamous cell carcinomas: Relationship with clinicopathologjc factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:593-600.
17. Bautista AM, Santiago R. Immunolocalization of p53, Glutathione S-transferase pi and CD57 antigens in oral leukoplakia. Anticancer Res 2001;21:379-86.
18. Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ et al. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol 2002;55:98-104.
19. Schildt EB, Nylander K, Eriksson M, Hardell L, Magnusson A, Roos G. Expression of p53, PCNA, ki-67 and bcl-2 in relation to risk factors in oral cancer -a molecular epidemiological study. Int J Oncol 2003;22:861-8.
20. Muraki Y, Tateishi A, Seta C, Fukuda J, Haneji T, Oya R et al. Fas antigen expression and outcome of oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2000;29:360-5.
21. Wakulich C, Jackson-Boeters L, Daley TD, Wysocki GP. Immunohistochemi-cal localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:573-9.
22. 6 integrin in oral leukoplakia. Brit J Cancer 2000;82:1433-40.
23. Bánkfalvi A, Krabort M, Végh A, Felszeghy E, Piffkó J. Deranged expression of the E-cadherin/b-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 2002;31:450-7.
24. Chung-Ji L, Yann-Jinn L, Hsin-Fu L, Ching-Wen D, Che-Shoa C, Yi-Shing L et al. The increase in the frequency of MICA gene A6 alkie in oral squamous cell carcinoma. J Oral Pathol Med 2002;31:323-8.
25. Nie M, Zhong L, Zeng G, Li B. The changes of cytokeratin 19 during carcino-genesis. Zonghua Kou Qiang Yi Xue Za Zhi 2002;37:187-90.
26. Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patient with oral leukoplakia. N Engl J Med 2001;344:1270-8.
27. Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. N Engl J Med 2001;344:1323-6.
28. Zhang L, Cheung K-J, Lam WL, Cheng X, Poh C, Priddy R et al. Increased genetic damage in oral leukoplakia from high risk sites. Cancer 2001;91:2148-55.
29. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000;6:347-52.
30. Piattelli A, Rubini C, Fioroni M, Iezzi G, Santineffi A. Prevalence of p53, bcl-2 and ki-67 immunoreactivity and of apoptosis in normal epithelium and in premalignant and malignant lesions of the oral cavity. J Oral Maxillofac Surg 2002;60:532-40.